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ABSTRACT OF THE DISSERTATION 
 
Executive Dysfunction is Predictive of Clinical Symptomatology in 
22q11.2 Deletion Syndrome 
 
by 
Chinonyere Kemdirim Bello 
Doctor of Philosophy, Graduate Program in Clinical Psychology  
Loma Linda University, December 2015 
Dr. Carrie Bearden, Dr. Richard Hartman, Chairpersons 
 
 
By adulthood, 25%- 30% of individuals with 22q11.2 deletion syndrome (22qDS) 
develop a psychotic disorder, often schizophrenia, and it is not understood why.  Given 
the known genetic etiology of this disorder and the greatly elevated risk for development 
of schizophrenia, this group offers the possibility of defining a seemingly homogenous 
maturational pathway to psychosis. Neurocognitive deficits have been increasingly 
recognized as an important dimension of schizophrenia, particularly in the executive 
domain. Thus, we assessed multiple aspects of executive cognition in 22qDS, in order to: 
1) characterize performance across this domain as compared to age-matched healthy 
controls; and 2) determine whether executive function performance is significantly 
predictive of positive and negative psychotic symptoms in 22qDS above and beyond non-
verbal functioning.  We assessed psychomotor speed and mental flexibility (Trails-B), 
working memory (Letter-Number Sequencing: LNS) and D-KEFS verbal fluency.  
Psychotic symptomatology was measured using scores obtained from the Structured 
Interview for Prodromal Syndromes (SIPS).  22qDS patients (N= 48, mean age: 15.23) 
showed impairment relative to healthy controls (N= 37, mean age: 14.97) on all measures 
of executive functioning.  Regression analysis revealed that executive deficits are 
xii 
predictive of positive psychological symptomatology above and beyond non-verbal 
deficits.  Specifically, D-KEFS verbal fluency added meaningfully to the prediction of 
positive psychiatric symptoms.  Given this significant prediction it is suggested that 
executive function may be an important domain for providing information about the 
development of psychosis.    
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CHAPTER ONE 
INTRODUCTION 
 
Schizophrenia 
Schizophrenia is a debilitating disorder that places a burden on the individual, 
family unit, and society (Harrison, & Weinberger, 2005).  The cost to the individual 
involves personal suffering, while the detriment to the family unit involves the burden of 
care giving.  Society is disrupted by the individual’s hospitalizations, need for long-term 
care, and loss of productivity (Davis & Drummond, 1994; Guest & Cookson, 1999).  A 
review by Knapp et al. (2004) examined the cost-of-illness estimate internationally.  They 
suggested that the expense includes national total, direct, and indirect costs; direct, 
indirect, and total costs per patient each year; inpatient services, medication, lost 
productivity, mortality, family impact, and criminal justice system costs.  Given the 
expenditure involved with schizophrenia, it is widely studied specifically for its genetic 
basis.  However, despite intensive search for the schizophrenia susceptibility gene, the 
genetic basis of this disorder remains elusive (Baron, 2001).   
22q11.2 deletion syndrome (22qDS) may provide a means of advancing our 
understanding of the pathophysiology underlying the development of schizophrenia.  By 
adulthood, approximately 25% to 30% of individuals with 22qDS develop a psychotic 
disorder, often schizophrenia (Bassett & Chow 1999; Murphy 2002; Murphy, Jones, & 
Owen, 1999; Murphy & Owen, 1996) and it is not understood why.  Due to the high 
frequency of schizophrenia in 22qDS patients, the 22q11.2 region is now thought to be 
one of the main schizophrenia susceptibility loci in humans (Bassett and Chow 2008; 
Insel 2010).  Cognitive deficits, particularly executive dysfunction are core features of 
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schizophrenia.  These deficits are relatively stable across clinical state changes and are 
present before the onset of clinical/psychotic symptoms (Levin et al. 1989; Crawford et 
al. 1993; Evans et al. 1997).  Executive deficits are also prominent in 22qDS.  Therefore 
given these relationships, we evaluated whether executive deficits are associated with 
clinical symptomatology.  
 
22q11.2 deletion syndrome 
22q11.2 deletion syndrome, velo-cardio-facial syndrome (VCFS), DiGeorge 
syndrome, and Shprintzen syndrome are all different names for a chromosomal deletion 
of one segment of the chromosome pair at band q11.2.  These syndromes were all 
originally thought to be different genetic conditions but it is now known that they all refer 
to individuals who have a 1.5 to 3 megabase (unit of length for DNA fragments) 
microdeletion on the long (q) arm of chromosome 22 (Shprintzen, 2008) (See Appendix 
A).  The 1.5 to 3 megabase microdeletion covers a region containing 35 to 60 genes 
(Drew et al., 2011; Edelmann et al., 1999).  The deletion can be detected by a diagnostic 
procedure called Fluorescence In Situ Hybridization (FISH).  This procedure is used to 
detect and localize the presence or absence of specific DNA sequences on chromosomes 
FISH uses fluorescent probes that bind to the missing segment of DNA on one 
chromosome if it is missing (Amann & Fuchs, 2008).  With this procedure, 22q11.2DS is 
now often detected in infancy via genetic testing. 
We will refer to this condition as 22qDS.  22qDS is one of the most common 
multiple anomaly syndromes in human beings.  Its prevalence is estimated at 1/4000 live 
births (Basset et al, 1998).  Up to 93% of cases occur de novo, whereas 7% of deletions 
are inherited from a parent (Phillip and Basset, 2011).  22qDS is characterized by 
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multiple developmental anomalies; over 180 have been identified (Shprintzen, 2000).  
These include cleft palate and velopharyngeal insufficiency which is a condition 
characterized by hypernasal speech, nasal emission and turbulence, and in some cases 
nasal regurgitation of fluids (Saunders, Hartley, Sell & Somerlad, 2004).  Furthermore, 
the anomalies include hypernasality, cardiac defects, endrocrinological and neurological 
problems (Robin & Shprintzen, 2005).  Craniofacial anomalies (cleft-palate, velo-
pharyngeal insufficiency) occur in 69-100% of children born with this syndrome.  
Thymic and parathyroid defects including hypocalcemia (low serum calcium blood 
levels) occur in 17-60% of children born with this condition.  Cardiovascular problems 
occur in 70% of children with 22qDS, as the first presenting symptom is usually a 
congenital heart defect (Robin and Shprintzen, 2005; Kobrynski and Sullivan, 2007).  
The multiple anomalies of 22qDS are associated with behavioral, psychiatric, and 
cognitive phenotypes. 
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CHAPTER TWO 
22Q11.2 DELETION SYNDROME 
 
Behavioral Phenotype of 22qDS 
The behavioral phenotype of 22qDS was first described by Golding- Kushner et 
al. (1985).  They suggested that there is a distinctive temperament that severely hinders 
successful social contact.  Golding-Kushner and colleagues explained a profile of 
withdrawn, socially isolated individuals that displayed “extremes of behavior” including 
disinhibition, impulsiveness, and shyness.   Papolos, Faedda, Veit, Goldberg, Morrow 
and Kucherlapati (1996) described a profile comparable to Golding-Kushner of 22qDS 
during childhood as they suggested this phenotype to include disinhibition, inattention, 
impulsivity, anxiety, schizoid features, social withdrawal, and flat affect.  Similarly, 
Antshel et al. (2007) found that children with 22qDS were rated by their parents as being: 
less regular in their daily habits; less able to focus/sustain attention; less 
cheerful/pleasant; less likely to stay with an activity for a long time; and less able to 
respond flexibly to changes in the environment.  Aneja et al., (2007) found that manic 
symptoms in 22qDS predicted significantly elevated scores on four Child Behavior 
Checklist (CBCL) subscales, namely anxiety, somatization, thought, and conduct 
problems.  There are other behavioral features indicated in 22qDS, but they are not well 
captured by standard assessment scales.  These include difficulties socializing, 
dependency on a caregiver, impulsivity, temper outbursts, perseverative speech and 
repetitive behaviors (Bassett et al., 2003; Swillen et al., 2000).  There is also an 
associated psychiatric phenotype with this syndrome, as described below.  
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Psychiatric Phenotype of 22qDS 
There are several psychiatric disorders related to 22qDS, with Attention deficit 
hyperactivity disorder (ADHD) being the most prevalent.  ADHD occurs in 
approximately one-third to half of all children with 22qDS (Gothelf, Presburger, Namani 
et al., 2004; Antshel et al., 2006; Zagursky et al., 2006).  High rates of affective disorders, 
anxiety disorders, phobic disorders, and obsessive- compulsive disorders in children and 
adults with 22qDS have been reported as well (Murphy, Jones, and Owen, 1999; 
Feinstein et al., 2002; Gothelf et al., 2004; Antshel et al., 2006).  Several studies have 
assessed and characterized psychiatric features in this population.   
In particular, using structured diagnostic interviews Papalos et al., 1996 found that 
64% (N = 16 of 25) of patients met DSM-III-R criteria for a spectrum of bipolar disorders 
with full syndromal onset in late childhood or early adolescence (mean age at onset = 12 
years, SD = 3).  In addition, 20% (N = 5) met DSM-III-R criteria for attention deficit 
hyperactivity disorder (ADHD), and 16% (N = 4) met criteria for attention deficit 
disorder without hyperactivity.  Similarly, using the Children's Interview for Psychiatric 
Symptoms, Child (ChIPS) and Parent (P-ChIPS) Forms (Weller et al., 2000), Jolin et al., 
1998) found that participants had a mean of two DSM-IV psychiatric disorders.  79% of 
these participants met criteria for at least one DSM-IV psychiatric disorder and over one 
third had three or more diagnoses.  12.5% met criteria for major depression, 54% for 
anxiety disorders, 38% for attention-deficit/hyperactivity disorder, and 38% for 
oppositional defiant disorder.  Notably, in adulthood many of these children develop 
psychoses, specifically schizophrenia.  
By adulthood, estimates of approximately 25%- 30% have been reported of 
individuals with 22qDS developing a severe psychiatric disorder, often schizophrenia 
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(Bassett & Chow 1999; Murphy 2002; Murphy, Jones, & Owen, 1999; Murphy & Owen, 
1996) and it is not understood why.  However, due to the high frequency of schizophrenia 
in 22qDS patients, the 22q11.2 region is now thought to be one of the main schizophrenia 
susceptibility loci in humans (Bassett and Chow 2008; Insel 2010).  Conversely, about 
1% of individuals with schizophrenia in the general population have 22q11.2 deletions 
(Bassett et al. 2010).   
In a sample of 100 patients with 22qDS Shprintzen et al. (1997) and Chow et al. 
(1999) found that by adulthood, 10-30% met criteria for chronic paranoid schizophrenia.  
This finding was congruent with what Shprintzen and colleagues discovered in 1992.  
They reported psychotic symptoms, which they described as resembling ‘‘chronic 
paranoid schizophrenia’’ in 12 of 90 children and adults with 22qDS (Shprintzen et al., 
1992).  Participants with 22qDS, an age and IQ matched control group, and the 
parents/caregivers for participants under age 16 completed a semi-structured interview.  
The Child and Adolescent Psychiatric Assessment (CAPA; Angold et al, 1995) was used 
to obtain a descriptive record of each participant’s current and previous (3 months) 
mental-state.  Psychiatric disorders were more prevalent among those with the syndrome 
and included attention deficit, depression, and anxiety symptoms.  Additionally, nearly 
half of the participants with 22qDS reported transient psychotic experiences (Baker and 
Skuse, 2005). 
Gothelf and colleagues conducted baseline psychiatric, psychological, and 
adaptive functioning evaluations of children with 22qDS and comparison subjects with 
idiopathic developmental disability matched for age and IQ.  Five years later the 
participants were evaluated again.  Although the two groups had similar baseline 
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neuropsychiatric profiles, at follow up 32% of the 22qDS group met DSM-IV criteria for 
psychotic depression, schizoaffective disorder, schizophrenia or schizophreniform 
disorder (Gothelf et al., 2007).  Furthermore, Murphy et al. (1999) evaluated adults with 
22qDS using either the Schedules for Clinical Assessment in Neuropsychiatry or 
Psychiatric Assessment Schedule for Adults With Developmental Disability if their IQ 
was lower than 50.  Results revealed that 30% of the adults with 22qDS had a psychotic 
disorder, and 24% met DSM-IV criteria for schizophrenia.  In addition to high rates of 
psychopathology and particularly psychosis, a characteristic cognitive profile has also 
been observed.  However, the specific cognitive risk factors for the development of 
psychosis have not yet been identified.  
 
Cognitive Phenotype of 22qDS 
22qDS is associated with general cognitive functioning in the low borderline 
range to mentally retarded range (Antshel et al, 2008; Eliez et al., 2000).  De Smedt, 
Devriendt, Fryns, Vogels, Gewillig, and Swillen (2007) found that 60% of the children 
showed borderline to normal intelligence (FSIQ > 70), whereas an intellectual disability 
(FSIQ < 70) was noted in 40% of the children.  The 22qDS cognitive profile includes 
impairment in speech and language.  Speech onset is mildly delayed and receptive 
language tends to develop more rapidly than expressive language.  These children often 
have a hypernasal speech pattern (75%) and articulation impairment (Golding-Kushner, 
2000).  
Neuropsychological testing in this population suggests a relative strength in 
verbal abilities relative to non-verbal abilities (Bearden, Woodin, Wang, Moss, 
McDonald-McGinn, Zackai, Emanuel, & Cannon, 2001; Wang et al., 1998).  In early 
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childhood, many individuals with the syndrome present with a cognitive profile that is 
similar to that profile identified in children with non-verbal learning disabilities (NVLD), 
i.e., performance IQ significantly lower than verbal IQ (Goldberg et al., 1992; De Smedt 
et al., 2009; Jacobson et al., 2010; Swillen et al., 1999; Moss et al., 1999; Swillen et al, 
2000).  Goldberg, Motzkin, Marion, Scambler, and Shprintzen (1992) suggests that this 
discrepancy is related to a combination of impairments in visuospatial ability, planning 
ability, non-verbal reasoning, and deficits in novel reasoning and concept formation.  
Henry, Van Amelsvoort, Morris, Owen, Murphy, and Murphy (2002) found that 
in comparison to demographically matched controls, 22qDS participants demonstrated 
significant impairments in visuoperceptual ability, problem solving and planning, and 
abstract and social thinking.  These demonstrated deficits are similar to the ones 
suggested by Goldberg and colleagues (1992).  
Bearden et al. (2001) assessed 22qDS children with a comprehensive 
neuropsychological battery to evaluate the nonverbal learning deficit that has been 
previously identified in this population.  A significant discrepancy was found between 
visual-spatial and verbal abilities within the domain of memory.  This was taken to 
suggest that a differential impairment in visual-spatial information-processing exists, 
consistent with the previously found non-verbal deficits.  Swillen et al. (1999) also found 
a Verbal IQ-Performance IQ discrepancy, in favor of VIQ, with significantly better 
scores for reading (decoding) and spelling.  Weaknesses were seen in arithmetic, tactile- 
perceptual skills, visual-perceptual abilities, visual-spatial skills, (extremely poor) 
psychomotor skills, processing of new and complex material, and visual attention.  Eliez 
et al. (2001) conducted a fMRI study of math reasoning in eight children with 22qDS.  
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Their results indicate that children with 22qDS showed less activation than controls in the 
angular gyrus, a posterior parietal brain region typically activated during such tasks.  In 
addition, increased activation was observed in the left supramarginal gyrus as a function 
of task difficulty.  Eliez et al. (2001) concluded that children with 22qDS may utilize an 
atypical and less effective circuit for completing math problems, which may lead to 
impairment.  Furthermore, visual attention impairment was also noted in a study by Sobin 
et al. (2005).  Deficits in executive function and planning are also a prominent part of the 
22qDS cognitive phenotype.  
Goldman-Rakic has defined executive function as a set of various interrelated 
cognitive abilities that operate metaphorically as a company ‘‘executive’’ and are thought 
to be largely mediated by prefrontal-parietal and prefrontal-subcortical circuits 
(Goldman-Rakic, 1995).  Executive function includes planning, cognitive flexibility, 
abstract thinking, rule acquisition, initiating appropriate actions and inhibiting 
inappropriate actions, and selecting relevant sensory information (Stuss and Knight, 
2002).  The executive functions that are most often evaluated in the 22qDS literature are 
cognitive flexibility, response inhibition, and working memory both verbal and 
nonverbal.  Previous research has demonstrated an executive deficit in 22qDS 
behaviorally, anatomically, and in the performance of neuropsychological tasks. 
In a study by Kiley-Brabeck and Sobin parents rated their child with 22qDS and 
the unaffected sibling with the Social Skills Rating System (SSRS) and Behavior 
Inventory of Executive Function (BRIEF).  Children with 22qDS had significantly lower 
SSRS ratings for cooperation, assertion, responsibility, and self-control.  On the BRIEF 
the 22qDS children had significantly higher ratings for initiation, planning, working 
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memory, and monitoring.  These results indicate that the children with 22qDS display 
poor executive functioning in that they have lower initiation, planning, working memory, 
and monitoring skills as compared to their unaffected siblings (Kiley- Brabeck and Sobin, 
2006).  
Sobin and colleagues also demonstrated a deficit in executive function in 22qDS 
as compared to their unaffected sibling.  Participants were administered a developmental 
neuropsychological assessment (NEPSY) and the Stanford–Binet Intelligence Scale. 
Although, no differences were found between the groups on tests of verbal or quantitative 
ability, children with 22qDS had impaired performance in the executive domain (Sobin et 
al., 2005).  An earlier study by Sobin et al. 2004 suggested an executive attention deficit 
in 22qDS as compared to unaffected siblings.  Performances on specific tasks have been 
indicative of executive dysfunction in 22qDS. 
Woodin et al. (2001) used the Trail-making Test to examine cognitive function in 
22qDS.  Their results suggested that children and adolescents with 22qDS struggle more 
on the Trail-making test Part B, a test of cognitive flexibility and set-shifting.  This result 
was suggestive of poorly developed working memory (Woodin et al., 2000).  Lajiness- 
O’Neill and colleagues examined the cognitive profile of children with 22qDS.  Visual-
spatial working memory was found to be less well developed than simple object memory 
(Lajiness- O’Neill et al., 2005).  On the Wisconsin Card Sorting Test, Lewandowski et al. 
(2007) reported that children with 22qDS made more perseverative errors than control 
participants.  Working memory deficits were demonstrated in a 22qDS group as 
compared to controls on a serial order task (Majerus et al., 2007).  Furthermore, Wang et 
al. (2000) assessed verbal working memory using a digit span task.  Children with 22qDS 
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performed less well than control participants.  Anatomical studies have also indicated an 
executive deficit involved in 22qDS. 
In 2007, Kates and colleagues used functional magnetic resonance imaging 
(fMRI) to examine neural activation during non-spatial working memory tasks in 
children with 22qDS, their unaffected siblings, and controls with the same proportion of 
learning disabilities as the 22qDS participants.  Intelligence and academic achievement 
were assessed with the Wechsler Intelligence Scale for Children, 3rd Edition and the 
Wechsler Individual Achievement Test, 2nd edition (WIAT-II).  A two–back, non-spatial 
working memory task was administered while the participants were in the scanner.  The 
task required participants to respond using a button box when they saw the same letter as 
two letters back for the experimental condition and during the control block, participants 
were asked to respond only to the letter “X”.  Results revealed that during the 
experimental condition (relative to the control condition) individuals with 22qDS 
exhibited significant activation in the left and right inferior frontal gyri and the left and 
right inferior parietal lobule.  However, in analyses where subjects were matched for 
performance, relative to performance-matched youth with 22qDS, both the control and 
the sibling samples recruited significantly more voxels in the frontal cortex, including the 
cingulate, the precentral gyrus, and the operculum.  These findings suggest that frontal 
lobe function is disrupted in youth with 22qDS (Kates et al., 2007). 
Another study by Kates and colleagues examined the morphology of the frontal 
lobe and the caudate nucleus in children with 22qDS.  Volumes of the caudate nucleus 
and frontal lobe were compared between 10 children with 22qDS and 10 matched 
controls.  Frontal deep white matter was reduced significantly (by about 23%) in 
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participants with 22qDS relative to controls.  Frontal and prefrontal volumes were also 
reduced as compared to controls.  These findings suggest frontostriatal dysfunction in 
children with 22qDS (Kates et al. 2004).  Cognitive impairment is also seen in 
psychoses/schizophrenia, with executive dysfunction being a prominent feature. 
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CHAPTER THREE 
PSYCHOSES/SCHIZOPHRENIA AND NEUROCOGNITION 
 
Research studies 
Neurocognitive deficits have been increasingly recognized as an important 
dimension of schizophrenia (Bilder et al., 2000; Green et al., 2000).  Wide ranges of 
cognitive impairments have been reported in people with schizophrenia, particularly 
problems in attention, verbal and working memory, and executive function (Rushe et al., 
1999; Morris et al., 1995; Kravariti et al., 2003).  
Kravariti and colleagues investigated cognitive function in adolescents with 
recent onset schizophrenia as compared to healthy controls.  A comprehensive battery 
was used including measures of intelligence, memory, and executive function paradigms.  
Specifically, the executive paradigms evaluated were planning and problem solving, 
spatial working memory, sequencing and mental flexibility, and dual-task performance. 
Significant deficits were seen in the schizophrenia participants as compared to the 
controls.  Deficits were seen in full scale IQ, performance IQ, verbal memory, visual 
memory, general memory, delayed recall, perceptual-motor processing time, between-
search errors/spatial working memory, and spatial strategy.   
Problem solving ability was examined in participants with schizophrenia (DSM-
III-R diagnosis) as compared to controls.  The 3-D computerized Tower of London task 
was used.  Participants with schizophrenia showed impairments in motor initiation and 
execution.  They were also impaired on accuracy of problem solving which includes 
number of moves above the minimum and number of problems solved using the 
minimum number of moves.  Results indicated that the schizophrenia group demonstrated 
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a pattern of performance that is similar to performances by participants with frontal lobe 
lesions (Morris, Rushe, Woodruffe, and Murray, 1995).   
Holmen and colleagues examined whether a battery of tests, the Measurement and 
Treatment Research to Improve Cognition in Schizophrenia (MATRICS), would be 
useful in detecting differences between a schizophrenia group and healthy controls.  
Speed of processing, attention/vigilance, working memory, verbal learning, visual 
learning, reasoning and problem solving, social cognition, and intelligence were assessed. 
There were significant differences in the performances between the schizophrenia group 
and the controls on every domain except for social cognition.  There was a generalized 
neurocognitive deficit of 0.8–1.8 SD’s compared with controls, with verbal learning, 
working memory, and visual learning being the most affected areas (Holmen et al., 
2010). 
Bressi et al. (1996) evaluated the hypothesis that patients with schizophrenia have 
an impaired central executive component of working memory.  Participants with 
schizophrenia (DSM-IV criteria) and age-education matched controls were asked to 
combine the performance on a computerized tracking task with articulatory suppression, 
simple reaction time (RT) to a tone, or auditory digit span concurrently.  The 
schizophrenia group’s performance deteriorated when tracking was combined with 
reaction time.  The authors concluded that these results are reflective of a dysfunction of 
central executive working memory in schizophrenia (Bressi et al., 1996).  
Bilder and colleagues aimed to provide a comprehensive neuropsychological 
characterization of participants with schizophrenia after the first episode of illness as 
compared to healthy controls.  Participants met diagnostic criteria for paranoid, 
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disorganized, catatonic, and undifferentiated schizophrenia or schizoaffective disorder.  
Neuropsychological testing was conducted to assess the language, memory, attention, 
executive, motor, and visuospatial domains.  Results revealed that the schizophrenia 
group was more impaired than the comparison group on every neuropsychological 
dimension measured.  The overall profile mean for the patients was –1.53, indicating a 
generalized deficit of approximately 1.5 standard deviations.  The schizophrenia group 
showed greater impairment on certain domains.  Specifically, this group demonstrated 
significantly more impairment on memory and executive areas (Bilder et al., 2000). 
Toulopoulou, Morris, Rabe-Hesketh, and Murray (2003) evaluated memory and 
executive processing in a group of schizophrenic patients, their healthy relatives, and 
normal controls.  Verbal and visual memory was assessed as well as various aspects of 
executive function (problem solving, planning ability, spatial working memory, working 
memory, strategy formation, mental flexibility).  Neuropsychological function in the 
patients was lower than that of their relatives, which in turn was lower than that of 
controls on most measures.  Verbal memory/learning and visual memory/learning were 
impaired as well as aspects of executive function including planning and spatial working 
memory (Toulopoulou et al., 2003).  
 
Deficits in cognition 
Cognitive impairment is considered a core feature of schizophrenia that includes 
problems in speed of processing, attention/vigilance, verbal learning, visual learning, 
social cognition and executive aspects including working memory, cognitive flexibility, 
planning, and reasoning and problem solving (Green 2006, Goldman-Rakic 1986; 
Goldberg et al. 1990; Morris et al. 1995).  As a core feature, these cognitive deficits are 
16 
not attributed to the symptoms of schizophrenia or of the treatment of the illness with 
antipsychotic medication.  Instead, cognitive deficits are relatively stable across clinical 
state changes, present before the onset of clinical/psychotic symptoms, and may be seen 
in attenuated form in unaffected first-degree relatives of people with schizophrenia 
(Finklestein et al., 1997; Gold 2004; Crow, Done, and Sacker, 1995).  Given this, it is 
important to assess cognitive function in 22qDS, considering its relationship with 
schizophrenia.  Deficits in cognition, specifically executive deficits given their 
consistency and prominence in schizophrenia, may be associated with conversion to this 
disorder in 22qDS.  Therefore, assessing whether these deficits are associated with 
psychological symptoms in 22qDS is valuable.  
It is important to understand the predictors of schizophrenia in 22qDS given that 
schizophrenia is considered to be the most expensive and difficult psychiatric disorder to 
treat (Capri 1994; Torrey 2002; Knapp 1997).  One of the factors that greatly contributes 
to the cost and difficulty in treating the illness is functional impairment (Kenny and 
Meltzer, 1991).  In 1996 Green suggested that these core cognitive deficits are an 
enduring feature of the illness and that these deficits are more important than positive and 
negative symptoms in predicting functional outcome. 
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CHAPTER FOUR 
MATERIALS AND METHODS 
 
Objective 
Given that people with 22qDS have high rates of psychosis in adulthood and it is 
not understood why, we are attempting to identify factors that might be associated with 
who is likely to develop psychosis.  Executive functioning is a prominent feature in 
schizophrenia, thus we believe that executive deficits will be associated with psychotic 
symptoms.  In fact in a study of four patients with 22qDS who developed schizophrenia, 
they were retrospectively discovered to have displayed delayed motor development, 
language deficits, learning disabilities, mental retardation, early age of onset, chronic and 
disabling course of illness and poor response to classical neuroleptic drugs and 
electroconvulsive therapy before adulthood (Gothelf et al., 1999).  Premorbid assessment 
may have been able to identify these differences.  Thus, we intend to evaluate child to 
early adulthood participants with 22qDS in terms of executive functioning to characterize 
performance across this domain as compared to age-matched healthy controls and to 
determine if executive deficits are associated with psychotic symptoms.  Given that 
psychoses do not fully manifest until adulthood, efforts to recognize the more mild, 
subthreshold psychotic symptoms that occur in 30–50% of youth with 22qDS (Feinstein 
et al., 2002; Baker & Skuse, 2005), will be valuable.  Increased methods to identify these 
premorbid symptoms are needed.  It is possible that 22qDS patients who eventually 
develop psychosis exhibited subthreshold psychotic symptoms early on that differentiated 
them from those that did not go on to develop a psychotic disorder (Gothelf et al., 2004).  
We will examine if these subthreshold symptoms can be indicated by executive 
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dysfunction.  Using executive deficits as an indication of psychopathology in 22qDS 
participants is novel. 
Although non-verbal learning deficits are characteristic in 22qDS, we speculate 
that executive function deficits will provide greater association with psychotic symptoms.  
Therefore, we will examine if executive deficits are associated with psychopathology 
above and beyond non-verbal deficits.  We will evaluate the following hypotheses: 
 
Hypotheses 
1. 22qDS patients will show the greatest impairment relative to healthy controls on 
measures of psychomotor speed and mental flexibility (Trail-making test part B), 
working memory (Letter-Number Sequencing), and the D-KEFS verbal fluency 
composite. 
2.  Executive deficits in working memory (Letter-Number Sequencing), and the D-
KEFS verbal fluency composite will be significantly predictive of total positive 
and total negative symptomatology above and beyond non-verbal visuospatial 
deficits (copy portion of the Rey Osterrieth Complex Figure Test) in 22qDS 
patients.   
 
Study Design 
A cross-sectional design was used for this project.  This project focused upon the 
Trail-making Test Part B, University of Maryland Letter-Number Span, and DKEFS 
Verbal Fluency as measures of executive function.  To examine non-verbal function, the 
Rey Osterrieth Complex Figure Test was evaluated (ROCFT).  The Structured Interview 
for Prodromal Syndromes (SIPS) was used to measure psychiatric symptoms.  Psychotic 
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symptom severity is defined as a quantitative trait, according to SIPS criteria (i.e., ratings 
range from 0 [not present] to 6 [‘severe and psychotic’]).  Dimensional ratings of 3 or 
higher on SIPS positive symptoms (“prodromal” or sub-psychotic range) are associated 
with high rates of subsequent conversion to overt psychosis and are also associated with 
substantial functional impairment.  Total positive and total negative symptoms were 
obtained by adding together the ratings of individual questions. 
 
Trail-making Test Part B 
The Trail Making Test (Reitan and Wolfson, 1985) is a measure of attention, 
speed, and mental flexibility.  It requires the participant to connect encircled numbers 
randomly arranged on a page in proper order and then encircled numbers and letters in 
alternating order.  Test re-test reliability in young adults retested after an interval of three 
weeks on the TMT B was .75 (Bornstein et al., 1987).  Inter-rater reliability for the TMT 
has been reported as .94 for part A and .90 for part B (Fals-Stewart, 1991).  The validity 
of the TMT shows that Parts A and B correlate moderately well with each other (r= .31 to 
.60) suggesting that they measure similar although somewhat different functions 
(Heilbronner et al., 1991; Pineda and Merchan, 2003; Royan et al., 2004).  Royan et al. 
(2004) reported that the TMT-B correlated moderately well with scores on other 
measures of speeded processing (i.e., Symbol Digit Modality Test and a variant of the 
PASAT). 
 
University of Maryland Letter-Number Span 
The University of Maryland Letter-Number Span task is a measure of verbal 
working memory.  This task requires mental reordering of orally presented lists with 
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letters and numbers and repeating them back (Holmen at al., 2010).    
 
D-KEFS Verbal Fluency 
The Delis-Kaplan Executive Function System (D-KEFS) (Delis, et al., 2001) was 
designed to detect even the mildest forms of executive dysfunction (Delis, et al., 2004).  
The D-KEFS Verbal Fluency Test requires the participant to say words that begin with a 
specified letter, say words that belong to a designated semantic category, and alternate 
between saying words from two different semantic categories.  The internal consistency 
for the verbal fluency test is reported to be marginal (.60-.69), however the test re-test 
reliability is adequate (.70-.79).  In terms of validity, it ranges from .44 to .83 when 
comparing semantic category switching and letter fluency (Delis et al., 2004).  This study 
utilized various aspects of verbal fluency including phonemic fluency, semantic fluency, 
category switching and switching accuracy.  These aspects were averaged to create an 
overall verbal fluency composite score.  
 
Rey Osterrieth Complex Figure Test 
The Rey-Osterrieth Complex Figure Test (ROCFT) was designed to assess visual-
spatial constructional ability and visual memory.  Examinees are asked to reproduce a 
complicated line drawing, first by copying and then from memory.  It was developed by 
Rey (1941) and then was elaborated by Osterrieth (1944).  Internal consistency was 
calculated by computing split-half and alpha coefficients (Berry et al., 1991; Fasteneau et 
al., 1996).  Both split-half and coefficient alpha reliabilities were greater than .60 for the 
copy condition and .80 for recall conditions.  Meyers and Meyers (1995) correlated 
scores of normal individual’s performances on the ROCF and found the largest 
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correlations to be between immediate recall and delayed recall (r= .88).  Immediate recall 
and delayed recall demonstrated low, but significant correlations with Recognition Total 
Correct (r= .15).  
 
The Structured Interview for Prodromal Syndromes (SIPS) 
The SIPS is a structured diagnostic interview used to identify the three prodromal 
syndromes.  These syndromes are thought to be (1) frankly psychotic positive symptoms 
that appeared too brief and too intermittent to constitute a fully psychotic syndrome, (2) 
attenuated positive symptoms, and (3) functional decline in the presence of genetic risk 
(Yung et al. 1996, 1998).  The SIPS includes the SOPS, the Schizotypal Personality 
Disorder Checklist (APA 1994), a family history questionnaire (Andreasen et al. 1977), 
and a version of the Global Assessment of Functioning scale (GAF; Hall 1995).  The 
SIPS is used to operationally define the three prodromal syndromes using the Criteria of 
Prodromal Syndromes (COPS) and psychosis onset by evaluating the Presence of 
Psychotic Syndrome (POPS).  Information from the COPS and the POPS are evaluated in 
terms of the positive symptoms of the schizotypal personality disorder checklist and the 
family history questionnaire in order to determine if a diagnosis of a prodromal syndrome 
or the presence of psychosis should be given.  This diagnostic interview addresses 
positive, negative, disorganized, and general symptoms (see Appendix C).  For the 
purposes of this study, we will only be focusing on total positive and total negative 
symptoms.   
 
Research Site and Procedures 
Participants between the ages of 10 and 25 with previously confirmed 22q11.2DS 
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were recruited through distribution of fliers to research sites and genetic clinics as well as 
word-of-mouth.  Interested families contacted the research coordinator at UCLA and 
underwent an initial phone screening to determine eligibility.  On the day of the visit, the 
child undergoes cognitive testing, magnetic resonance imaging (MRI), a blood draw, and 
the Autism Diagnostic Observation Schedule (ADOS).  Depending on the age and 
cognitive ability, he or she is also asked to complete a short packet of questionnaires.  
The parent completes the Autism Diagnostic Interview-Revised (ADI-R), the Diagnostic 
Interview Schedule for Children (DISC), and a packet of questionnaires.  Cognitive 
testing was conducted by advanced graduate students in clinical psychology and took 
place in a quiet room.  The MRI was conducted at the Abrahamson-Lovelace Brain 
Mapping Center and autism diagnostic measures were administered by trained staff at the 
UCLA Autism Evaluation Clinic.  All families received a summary report that included 
the results of cognitive testing as well as diagnostic impressions. 
 
Cognitive Testing 
The testing battery included measures of visuospatial ability such as the Rey 
Osterrieth Complex Figure Test (ROCFT) and the Children’s Memory Scale (CMS) 
Faces and Dot Locations.  The ROCFT is designed to assess visual-spatial constructional 
ability and visual memory (Rey, 1941; Osterrieth, 1944).  Examinees are asked to 
reproduce a complicated line drawing, first by copying and then from memory.  CMS 
Faces and Dot Locations assess recall for spatial location and recognition of human faces 
(Cohen, 1997).  Social cognition was measured with the Animations task, Penn Emotion 
Identification/Discrimination Tasks, and Awareness of Social Inference Task (TASIT).  
The Animations task requires the examinee to observe shapes on a screen performing 
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human-like actions and describe what the shapes are doing.  The Penn Emotion 
Identification/Discrimination Tasks is a computer-based test that includes 96 color 
photographs of facial expression of evoked or felt emotions: happy, sad, angry, fearful, 
disgusted, and non-emotional or neutral.  Participants are asked to rate the emotional 
valence of each expression (Kohler, Turner, Bilker, Brensinger et al. 2003).  The TASIT 
is an audiovisual tool designed for the clinical assessment of social perception.  The task 
assesses emotion recognition, the ability to interpret conversational remarks meant 
literally (i.e., sincere remarks and lies) or non-literally (i.e., sarcasm) as well as the ability 
to make judgments about the thoughts, intentions and feelings of speakers (McDonald, 
Bornhofen, Shum, Long, et al., 2007).  Memory was assessed with the California Verbal 
Learning Test for children (CVLT-C).  The CVLT-C requires the examinee to recall two 
word lists over immediate and delayed memory trials (Delis et al., 1994).  Speed of 
processing was measured with the Brief Assessment of Cognition in Schizophrenia 
Symbol Coding (BACS).  The BASC is a timed task where the examinee is asked to use a 
key to write numbers that correspond to nonsense symbols (Keefe et al., 2004).  
Attention, psychomotor speed and mental flexibility was measured with the Trail-making 
Test Part A & B.  It requires the subject to connect by making pencil lines, encircled 
numbers randomly arranged on a page in proper order (Part A) or for Part B encircled 
numbers and letters in alternating order (Reitan, 1955).  General cognitive 
function/assessment of premorbid intelligence was assessed using the WASI Matrix 
Reasoning & Vocabulary.  Matrix reasoning requires the respondent to look at a picture 
with a section missing and identify the missing part by pointing or by the number of one 
of five choices and the vocabulary task requires the respondent to provide oral definitions 
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to words (The Psychological Corporation, 1999).  The University of Maryland Letter-
number Span task was used to measure working memory.  This task requires mental 
reordering of orally presented lists with letters and numbers and repeating them back 
(Holmen at al., 2010).  Executive function was measured with the Delis-Kaplan 
Executive Function System Verbal Fluency (D-KEFS).  The D-KEFS Verbal Fluency 
Test requires the participant to say words that begin with a specified letter, say words that 
belong to a designated semantic category, and alternate between saying words from two 
different semantic categories (Delis, et al., 2004).  Attention was measured by Simple 
Reaction Time, the Continuous Performance Test (CPT-II), and Time Reproduction.  
Simple reaction time is a computerized task that requires the subject to press a button 
whenever they see the target stimulus appear on the screen.  The CPT-II is a computer-
administered measure of sustained attention in which the respondent presses a response 
button whenever they see consecutive matching numbers.  Risk taking behavior was 
assessed with the Balloon Analog Risk Task (BART).  In the BART the participant is 
presented with a balloon and offered the chance to win a prize by pumping the balloon up 
by clicking a button. Each click causes the balloon to incrementally inflate and earn the 
participant points to be added to a counter up until some threshold, at which point the 
balloon is over inflated and explodes (Lejuez et al., 2002).   
 
Interviews/Questionnaires 
The Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al. 
2001; Miller et al. 2002; Rosen et al. 2002) and Autism Diagnostic Observation Schedule 
(ADOS) are conducted.  The parent completes the Autism Diagnostic Interview-Revised 
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(ADI-R), the Diagnostic Interview Schedule for Children (DISC), and a packet of 
questionnaires. 
 
Statistical Analyses 
T-tests 
In order to evaluate the hypothesis 22qDS patients will show the greatest 
impairment relative to healthy controls on measures of psychomotor speed and mental 
flexibility (Trail-making test part B), working memory (Letter-Number Sequencing), and 
the D-KEFS verbal fluency composite, T-tests were run.  T-tests were also run with 
comparison measures outside of the executive domain namely, Vocabulary, Matrix 
Reasoning, and the Rey Osterrieth Complex Figure test (copy portion).  Effect sizes were 
also calculated for all of these measures to assess the magnitude of the difference 
between the patient and control groups.   
 
Pearson’s Correlations 
To determine the convergent and discriminant validity between and amongst the 
executive measures, visuospatial ability, and total positive and total negative psychotic 
symptoms and to determine which predictor variables (dependent variables) to include in 
the regression analyses, Pearson’s correlations were calculated.  
 
Regression 
In order to evaluate the hypothesis executive deficits in working memory (Letter-
Number Sequencing), and the D-KEFS verbal fluency composite will be significantly 
predictive of total positive and total negative symptomatology above and beyond non-
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verbal visuospatial deficits (copy portion of the Rey Osterrieth Complex Figure Test) in 
22qDS patients, multiple regression analyses were conducted.  For the regression analysis 
predicting total positive symptoms, in order to control for age, age was entered into the 
first block.  Visuospatial ability was included in the second block and working memory 
and the verbal fluency composite score were entered into the third block.  For the 
regression analysis predicting total negative symptoms, age was also controlled for.  
Visuospatial ability was entered into the second block.  Only working memory was 
entered into the third block because the verbal fluency composite score was not 
significantly correlated with total negative symptoms.    
 
Power Analyses 
A post hoc power analysis was conducted using the software package, G*Power 
(Faul and Erdfelder, 1992) to determine the power for our t-tests.  Our sample size of 48 
for our patient group and sample size of 37 for our control group was utilized.  The alpha 
level used for this analysis was p < .05.  The post hoc analysis revealed that with the 
statistical power for our t-test we had a 98% chance to detect a large effect (i.e., Cohen’s 
d of .80), a 73% chance to detect a medium effect (i.e., Cohen’s d of .50) and a 23% 
chance to detect a small effect (i.e., Cohen’s d of .20) given our sample size.   
A post hoc power analysis was also conducted for our regression analyses.  The 
post hoc analysis revealed that the statistical power for our regressions produced a 92% 
chance to detect a large effect (i.e., f2= .35), 56% chance to detect a medium effect (i.e., 
f2= .15) and an 11% chance (i.e., f2= .02) to detect a small effect given our sample size.  
Thus, for both the t-test and regressions there was more than sufficient power at the large 
effect size but less than adequate power at the small effect size. 
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CHAPTER FIVE 
RESULTS 
 
Independent Samples T-tests 
T-tests were run to analyze significant differences between 22qDS patients and 
controls on executive measures and other comparison tests including Vocabulary, Matrix 
Reasoning, and the Rey Osterrieth Complex Figure test (copy portion).  Effect sizes were 
also calculated and these results are depicted in Figure 1.  22qDS patients (N= 48, mean 
age: 15.23) showed impairment relative to healthy controls (N= 37, mean age: 14.97) on 
all measures of cognition.  See table 1 for subject demographics and table 2 for results of 
t-tests.  
 
 
 
Figure 1.  Group Differences. 
Note.  Cognitive measure effect sizes.  ROCFT= Rey Osterrieth Complex Figure test 
copy portion; Matrix= Matrix Reasoning; TMT-B= Trail-making test part B; LNS= 
Letter Number-Sequencing; DKEFS Comp= Delis-Kaplan Executive Function System 
composite score. Composite score calculated as the average of phonemic fluency, 
semantic fluency, category switching and switching accuracy.  
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Table 1 
 
  
Subject Demographics  
 22qDS (N=48) Controls (N=37) 
Age 15.23 14.97 
Gender (N, % female) 26 (54.2%) 17 (45.9%) 
N, % race    
Caucasian 42 (87.5%) 22 (59.5%) 
Black/African American  1 (2.1%) 5 (13.5) 
Asian  0 (0.0%) 3 (8.1%) 
Multiple 5 (10.4%) 7 (18.9%) 
 
 
 
Table 2 
 
    
Mean Scores of Cognitive Measures for 22qDS and Controls  
Groups 
 22qDS Controls t df 
Working Memory  10.3542 
(5.12603) 
14.7568 
(4.03736) 
-6.773* 83 
Verbal Fluency 
Composite 
61.9323 
(17.43893) 
89.9054 
(23.04271) 
-6.373* 83 
Psychomotor 
Speed/Mental 
Flexibility  
113.5585 
(65.38445) 
63.8951 
(27.73643) 
4.657* 81 
Visuospatial Ability 22.5114 
(6.66254) 
30.2222 
(5.76497) 
-5.467* 78 
Vocabulary 36.5625 
(10.58282) 
55.1081 
(13.82386) 
-6.773* 83 
Matrix Reasoning 15.333 
(7.60552) 
24.8378 
(6.30482) 
-6.295* 83 
Note.  *p< .01.  Standard Deviations appear in parentheses below means. 
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Pearson’s Correlations 
To determine the convergent and discriminant validity between and amongst the 
executive measures, visuospatial ability, and total positive and total negative psychotic 
symptoms and to determine which predictor variables to include in the regression 
analyses, Pearson’s correlations were calculated.  Results are listed in Table 3.  The 
executive measures that significantly correlated (p < .05) with total positive and total 
negative psychiatric symptoms were included in the regression analyses.  Working 
memory (Letter-Number Sequencing) and the Verbal Fluency Composite Score (Average 
of D-KEFS verbal letter fluency, category fluency, category switching, and switching 
accuracy) were significantly correlated with total positive symptoms, p < .05.  Only 
working memory was significantly correlated with total negative symptoms.  
Psychomotor speed and mental flexibility (Trail-making test part B) was not significantly 
correlated with total positive and total negative symptoms.  Therefore, it was not included 
in the regression analyses.   
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Table 3       
Summary of Correlational Analyses for Executive Measures and SIPS Symptoms 
 Working 
Memory 
Verbal 
Fluency 
Psychomotor 
speed 
Visuospatial 
Ability 
Positive 
Total 
Negative 
Total 
Working 
Memory  
_ .545** -.559** .334* -.431** -.369* 
Verbal 
Fluency 
.545** _ -.369* .587** -.481** -.274 
Psychomotor 
speed 
-.559** -.369 _ -.207 .007 .177 
Visuospatial 
Ability  
.334* .587** -.207 _ -.203 -.295 
Positive 
Total  
-.431** -.481** .007 -.203 _ .528** 
Negative 
Total  
-.369* -.274 .177 -.295 .528** - 
Note. * p<.05; ** p<.01. Verbal Fluency= Verbal Fluency Composite Score, 
Psychomotor speed= Psychomotor speed/mental flexibility. 
 
 
Regression 
To address the hypothesis that deficits on D-KEFS verbal fluency composite, and 
working memory (Letter-Number Sequencing) will be significant predictors of SIPS total 
positive and total negative symptoms, and will be significantly predictive of positive and 
negative symptomatology above and beyond non-verbal visuospatial deficits (copy 
portion of the Rey Osterrieth Complex Figure Test) in 22qDS patients, multiple 
regression analyses were conducted.  Overall, this analysis was used to determine if the 
addition of executive measures would improve prediction of psychotic symptoms beyond 
that afforded by visuospatial ability.  
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Results revealed that the optimal linear combination of age, the copy portion of 
the Rey-Osterrieth Complex Figure Test, Letter-Number Sequencing, and the D-KEFS 
verbal fluency composite score accounted for 32% of the variance in total positive 
psychiatric symptoms (R2 = .32).  On average for every one-point increase in the D-KEFS 
verbal fluency composite score, total positive symptoms decreased by .224 points (b = -
.224, 95% CI [-.407, -.041], p < .05).  The copy portion of the Rey Osterrieth Complex 
Figure test (b = .144, 95% CI [-.268, .555], p > .05 and Letter-Number Sequencing (b = -
.358, 95% CI [-1.088, .371], p > .05; were not significant individual predictors.  
Therefore, the model was driven by the D-KEFS verbal fluency composite score.  See 
figure 2 and table 4. 
 
 
Figure 2.  Variance Explained by Regression with Rey Osterrieth Complex Figure Test 
Copy Portion and Executive Measures Predicting Total Positive Symptoms 
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Table 4 
 
      
Results of Hierarchical Regression Analysis with Visuospatial Ability and Executive 
Measures Predicting Total Positive Symptoms  
 b β t Sig. 95% CI (b) ΔR2 
Step 1      .000 
(Constant) 7.255  1.519 .140 [-2.513, 17.022]  
Age  .002 .001 .008 .994 [-.602, .606]  
Step 2      .045 
(Constant) 10.857  1.906 .067 [-.811, 22.525]  
Age .098 .062 .321 .750 [-.527, .723]  
Visuospatial 
ability  
-.219 -.220 -1.146 .261 [-.609, .179]  
Step 3      .279* 
(Constant) 14.583  2.846 .009 [4.051, 25.116]  
Age  .424 .267 1.486 .149 [-.162, 1.010]  
Visuospatial 
ability  
.144 .145 .718 .479 [-.268, .555]  
Working 
memory 
-.358 -.202 -1.010 .322 [-1.088, .371]  
Verbal Fluency 
Composite 
-.224 -.569 -2.511 .019 [-.407, -.041]  
 
 
There were no linear combinations that resulted in significance regarding total 
negative symptoms.  Additionally, the copy portion of the Rey-Osterrieth Complex 
Figure Test (b = .226, 95% CI [-.663, .211], p < .05), and Letter Number Sequencing (b = 
-.657, 95% CI [-1.439, .125], p < .05) were not found to be significant individual 
predictors of negative symptoms.  See figure 3 and table 5. 
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Figure 3.  Variance Explained by Regression with Rey Osterrieth Complex Figure Test 
Copy Portion and Executive Measures Predicting Total Negative Symptoms 
 
Table 5 
 
      
Results of Hierarchical Regression Analysis with Visuospatial Ability and Executive 
Measures Predicting Total Negative Symptoms 
 b β t Sig. 95% CI (b) ΔR2 
Step 1      .012 
(Constant) 6.242  1.202 .239 [-4.375, 16.860]  
Age  .193 .111 .601 .553 [-.464, .849]  
Step 2      .114 
(Constant) 12.540  2.105 .044 [.338, 24.742]  
Age .360 .207 1.128 .269 [-.294, 1.014]  
Visuospatial 
Ability  
-.382 -.352 -1.916 .066 [-.791, .026]  
Step 3      .087 
(Constant) 13.290  2.302 .029 [1.443, 25.138]  
Age  .460 .264 1.464 .155 [-.185, 1.104]  
Visuospatial 
Ability  
-.226 -.208 -1.060 .299 [-.663, .211]  
Working 
Memory  
-.657 -.339 -1.724 .096 [-1.439, .125]  
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Discussion 
We hypothesized that 22qDS patients will show the greatest impairment relative 
to healthy controls on measures of executive functioning and non-executive comparison 
measures.  This investigation partially confirmed our hypothesis as 22qDS patients 
showed impairment relative to healthy controls on psychomotor speed and mental 
flexibility (Trail-making Test Part B), working memory (Letter-Number Sequencing), 
verbal fluency (Composite score: D-KEFS phonemic fluency, semantic fluency, category 
switching and switching accuracy), non-verbal abstract problem solving (Matrix 
Reasoning), Vocabulary, and visuospatial ability (Rey Osterrieth Complex Figure test 
copy portion).  However, we also calculated effect sizes to assess the magnitude of the 
difference between the two groups on cognitive measures.  As depicted in figure 1, large 
effect sizes were demonstrated for Vocabulary (Cohen’s d= 1.51), Matrix Reasoning 
(Cohen’s d= 1.36), and the Rey Osterrieth Complex Figure test copy portion (Cohen’s d= 
1.24).  Although the 22qDS group appears to show deficits in multiple domains, we 
believe executive function deficits are more relevant to psychotic symptom development.  
This makes sense given that the Rey Osterrieth Complex Figure test copy portion was not 
significantly correlated with positive or negative symptoms while the executive measures 
were.     
Our second hypothesis purported that deficits on the verbal fluency composite, 
psychomotor speed and mental flexibility (Trail-making Test Part B), and working 
memory (Letter- Number Sequencing) will be significant predictors of total positive and 
total negative symptoms, above and beyond non-verbal visuospatial deficits (copy 
portion of the Rey Osterrieth Complex Figure Test) in 22qDS patients.  This hypothesis 
was partially supported.  For the regression analysis predicting total positive symptoms, 
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executive measures accounted for 32% of the variance.  The D-KEFS verbal fluency 
composite scores drove this finding; executive measures did add meaningfully to the 
prediction of total positive symptoms.  This finding is inline with our hypothesis.  In the 
regression analysis predicting total negative psychological symptoms, however, the 
model was not significant and there were no significant individual predictors p> .05.  
This lack of significance may be due to the limited power.  We had an 11% chance to 
detect a small effect with our regressions given our sample size.   
Overall, these results can be interpreted to mean executive deficits are predictive 
of total positive symptoms above and beyond non-verbal visuospatial abilities.  This 
information is very useful because cognitive deficits within the executive domain are a 
prominent impairment also seen in schizophrenia.  Being that cognitive deficits are 
relatively stable across clinical state changes and present before the onset of 
clinical/psychotic symptoms (Finklestein et al., 1997; Gold 2004; Crow, Done, and 
Sacker, 1995), it is important to assess executive function in 22qDS, considering its 
relationship with schizophrenia.  The consistency and prominence of executive deficits in 
schizophrenia may be associated with conversion to this disorder in 22qDS.  Assessing 
whether these deficits are associated with positive and negative psychological symptoms 
in 22qDS is a novel and valuable pursuit.  
Along with Green (2006) we are in favor of evaluating cognitive deficits as they 
relate to schizophrenia.  Green suggests evaluating and treating cognitive deficits in 
patients that are currently suffering from schizophrenia.  He argues that cognitive deficits 
can serve as endophenotypes for the genetic basis of schizophrenia because they show 
characteristics that are associated with genetic vulnerability to the illness (Finkelstein, 
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Cannon, Gur et al., 1997).  We also believe that cognitive deficits, specifically executive 
deficits can serve as an endophenotype for the genetic basis of schizophrenia in 22qDS.  
Evaluating persons with 22qDS in terms of executive function over various time points 
will provide a different means to study and understand schizophrenia.  This information 
may lead to identifying executive dysfunction in 22qDS as a potential risk factor for the 
later development of psychoses/schizophrenia, which may aid in early detection.  Data 
has suggested that early intervention with medication in first-break patients with 
schizophrenia increases the likelihood of an improved long-term course (Wyatt, 1991).  
Using executive function as an endophenotypic marker for positive and negative 
psychological symptoms is a novel concept, can ultimately lead to early detection and 
earlier treatment, and some relief of the burden schizophrenia poses to the individual, the 
caregiver, and society.  
 
Limitations 
The limitation of our study was the issue of power.  A post hoc power analysis 
revealed that given our sample size of 48 in the 22qDS group we had an 11% chance to 
detect a small effect with our regressions.  We did not have any significant findings for 
our regression analysis with visuospatial ability and executive function predicting total 
negative symptoms.  Perhaps with more power to detect a small effect significant 
findings may have resulted with this regression.    
 
Future Directions 
Our results suggest that executive function may be an important domain for 
providing information about the development of psychosis.  This study utilized a cross 
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sectional design.  Future directions include employing a longitudinal design in order to 
detect progression of positive and negative psychotic symptoms over various time points.  
Furthermore, this research leads to questions regarding the neurobiological basis of 
executive function deficits in 22qDS.  Investigations of these questions are already 
underway.  Future directions also include replicating this study with a larger sample to 
insure greater power for detecting effects.  Replication of this study with a larger sample 
size may also lead to the creation of a questionnaire or battery of tests specifically used in 
the detection of increased psychiatric symptoms coupled with a decrease in executive 
function for patients with 22qDS.  
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APPENDIX A 
THE DEL22Q11.2 REGION ON CHROMOSOME 22 
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APPENDIX B 
FACIAL DYSMORPHIA 
 
 
Figure 2. Facial dysmorphia, characteristic facial feature in chromosome 22q11.2 
deletion syndrome. A slightly bulbous nose tip and hooded eyes are the primary features. 
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